Quadria Capital
Consumer
PE-backed food processing firm Capricorn gets SEBI nod to float IPO
Food pulp manufacturer Capricorn Food Products India Ltd has received approval from the country's markets regulator to float an initial ......
Finance
IQGEN raises maiden health-tech VC fund for India, other markets
IQGEN Holdings LLC has marked the final close of its maiden venture capital fund at $25 million (Rs 163 crore), ......
Healthcare
Quadria Capital backs Strand Life Sciences
Strand Life Sciences Pvt. Ltd, which focuses on clinical genomics and biotechnology research, has raised funds from healthcare-focussed private equity ......
Healthcare
Budget 2018: Govt announces world's largest health scheme, to benefit 500 mn poor
Finance Minister Arun Jaitley, on Thursday, announced the flagship National Health Protection Scheme (NHPS), which aims to provide an annual ......
Healthcare
Five trends to watch out for in healthcare sector in 2018
The healthcare sector is poised for an eventful 2018 as medical devices and pharmaceutical firms await key policy announcements, more ......
Healthcare
Flashback 2017: Pharma M&As hog limelight; multi-speciality hospitals get PE money
Large private equity investments in multi-specialty hospitals and sustained investor interest across the single-specialty space were the showstoppers in the ......
Healthcare
Is home healthcare sector still the heartthrob of investors?
In April, private equity firm Mahindra Partners led a $21-million funding round in home healthcare services provider Medwell Ventures Pvt. ......
Consumer
Capricorn Food explores IPO to let PE investor IBOF exit
Food pulp manufacturer Capricorn Food Products India Ltd is considering a public listing to allow India Build-Out Fund to exit ......
Healthcare
Company watch: Concord Biotech eyes new opportunities after Quadria's backing
Biotechnologist Sudhir Vaid quit drugmaker Ranbaxy Laboratories Ltd exactly 20 years ago to start his entrepreneurial journey. The Ahmedabad-based biotechnology ......
Healthcare
Why PEs, VCs are holding back from investing in the stem cell market
In 2009, when eight-year-old Thamirabarani was cured of thalassaemia, a rare blood disorder, LifeCell International Pvt. Ltd made ripples in ......
Recommended for you
Google News
Follow VCCircle on Google News for the latest updates on Business and Startup News